دورية أكاديمية
أعرض في EDS

Development of the paediatric society of the African league against rheumatism (PAFLAR) JIA registry and clinical profile of JIA in Africa from the PAFLAR JIA registry.

التفاصيل البيبلوغرافية
العنوان: Development of the paediatric society of the African league against rheumatism (PAFLAR) JIA registry and clinical profile of JIA in Africa from the PAFLAR JIA registry.
المؤلفون: Migowa AN; Department of Paediatrics, Aga Khan University Medical College East Africa Nairobi, P.O Box 30270, Nairobi, 00100, Kenya. angela.migowa@aku.edu., Hamdi W; Department of Rheumatology, Kassab Institute - Tunis El Manar University - Faculty of Medicine of Tunis, Tunis, Tunisia., Hashad S; Tripoli Children's Hospital, University of Tripoli, Tripoli, Libya., Etayari H; Tripoli Children's Hospital, University of Tripoli, Tripoli, Libya., Abushhaiwia A; Tripoli Children's Hospital, University of Tripoli, Tripoli, Libya., Ferjani H; Rheumatology Department, Kassab Institute of Orthopedics, Faculty of Medicine of Tunis, Tunis, Tunisia., Nessib DB; Department of Rheumatology, Kassab Institute - Tunis El Manar University - Faculty of Medicine of Tunis, Tunis, Tunisia., Kharrat L; Department of Rheumatology, Kassab Institute - Tunis El Manar University - Faculty of Medicine of Tunis, Tunis, Tunisia., Fazaa A; Department of Rheumatology, Mongi Slim Hospital - Tunis El Manar University - Faculty of Medicine of Tunis, Tunis, Tunisia., Owino L; Department of Paediatrics, Faculty of Health Sciences Nairobi, University of Nairobi, Nairobi, Kenya., Faleye A; Department of Paediatrics, Lagos State University Teaching Hospital Lagos, Lagos, Nigeria., Owusu SA; Department of Paediatrics and Child Health, University for Development Studies, Tamale, Ghana., Mosa DM; Department of Rheumatology and Rehabilitation, Faculty of Medicine, Mansoura University Hospital, Mansoura, Egypt., Eissa M; Department of Rheumatology, Cairo University, Cairo, Egypt., Nasef SI; Rheumatology Department, Suez Canal University, Ismailia, Egypt., Elsehrawy GG; Rheumatology Department, Suez Canal University, Ismailia, Egypt., Odhiambo R; Research Unit, Aga Khan University Medical College East Africa Nairobi, Nairobi, Kenya., Orwa J; Department of Population Health, Aga Khan University Medical College East Africa Nairobi, Nairobi, Kenya., Abu-Zaid MH; Faculty of medicine Tanta, Tanta University, Tanta, Egypt.
المصدر: Pediatric rheumatology online journal [Pediatr Rheumatol Online J] 2024 Jul 22; Vol. 22 (1), pp. 67. Date of Electronic Publication: 2024 Jul 22.
نوع المنشور: Journal Article; Observational Study
اللغة: English
بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 101248897 Publication Model: Electronic Cited Medium: Internet ISSN: 1546-0096 (Electronic) Linking ISSN: 15460096 NLM ISO Abbreviation: Pediatr Rheumatol Online J Subsets: MEDLINE
أسماء مطبوعة: Publication: 2007- : [London] : BioMed Central
Original Publication: [Chicago, Ill. : University of Chicago, 2003]-
مواضيع طبية MeSH: Registries* , Arthritis, Juvenile*/epidemiology , Arthritis, Juvenile*/drug therapy , Arthritis, Juvenile*/diagnosis, Humans ; Female ; Male ; Child ; Retrospective Studies ; Child, Preschool ; Africa/epidemiology ; Antirheumatic Agents/therapeutic use ; Societies, Medical ; Rheumatology
مستخلص: Background: The spectrum of Juvenile Idiopathic Arthritis (JIA) in Africa is still largely unknown. We thus set out to illustrate how we set up the PAFLAR JIA registry and describe the clinical profile of Juvenile Idiopathic Arthritis across various regions in Africa.
Methods: We carried out a retrospective observational cohort study where collaborators were trained on use of the existing PAFLAR REDCAP database to enter data for the JIA patients currently under their care capturing their epidemiological data, clinical features, laboratory investigations, diagnosis and therapy at initial diagnosis. Descriptive statistics including means, standard deviations, medians, interquartile ranges (IQR) for continuous variables and proportions for categorical variables were calculated as appropriate. Tests for difference between groups were performed between categorical variables using Pearson's chi-square or Fisher's exact tests. All analyses were performed using SPSS version 22 software.
Results: We enrolled 302 patients, 58.6% (177 of 302) of whom were female. The median age of disease onset was 7 years (range 3-11 years) and the median age at diagnosis was 8.5 years (range 5-12 years). The median duration delay in diagnosis was 6 months (range 1-20.8 months). The JIA categories included Systemic JIA 18.9% (57), Oligoarticular JIA 19.2% (83), Polyarticular RF + ve 5% (15), Polyarticular RF-ve 17.9% (54), Enthesitis Related Arthritis (ERA) 18.2% (55), Psoriatic Arthritis 7% (21) and undifferentiated JIA 5.6% (17). As regards treatment the commonest therapies were NSAID therapy at 31.1%, synthetic DMARDs at 18.1%, synthetic DMARDs combined with NSAIDs at 17.5% and steroid therapy at 9.6%. Biological DMARDs accounted for 2.3% of therapies offered to our patients at diagnosis. The average JADAS score was 10.3 (range 4.8-18.2) and the average CHAQ score was 1.3 (range 0.7-2.0).
Conclusion: Our study highlights strategies involved in setting up a Pan-African paediatric rheumatology registry that embraces our broad diversity and the vast spectrum of JIA in Africa while comparing the various therapies available to our patients. The PAFLAR JIA registry strives to ensure a comprehensive representation of the diverse healthcare landscapes within the continent. Further longitudinal observation studies are required to ascertain the long-term outcomes of our patients and ultimately help inform policy to create a more favorable health ecosystem to support the healthcare needs of JIA patients in Africa.
(© 2024. The Author(s).)
References: Arthritis Care Res (Hoboken). 2016 Dec;68(12):1874-1882. (PMID: 27015436)
RMD Open. 2018 Dec 05;4(2):e000780. (PMID: 30714579)
Front Med (Lausanne). 2022 Jun 09;9:880285. (PMID: 35755056)
Arthritis Rheum. 2007 Mar;56(3):722-9. (PMID: 17328042)
Pediatr Rheumatol Online J. 2014 Nov 25;12:49. (PMID: 25705138)
Pediatr Rheumatol Online J. 2012 Feb 02;10:5. (PMID: 22300325)
Best Pract Res Clin Rheumatol. 2020 Oct;34(5):101566. (PMID: 32727697)
Semin Arthritis Rheum. 2020 Aug;50(4):791-796. (PMID: 32540672)
Pediatr Rheumatol Online J. 2023 Dec 13;21(1):144. (PMID: 38093255)
Nat Rev Rheumatol. 2009 Nov;5(11):616-26. (PMID: 19806151)
J Rheumatol. 2010 Aug 1;37(8):1749-55. (PMID: 20595272)
Arthritis Rheum. 2007 Feb 15;57(1):44-8. (PMID: 17266088)
Arthritis Rheum. 2010 Dec;62(12):3528-36. (PMID: 20737466)
Int J Rheum Dis. 2020 Mar;23(3):443-447. (PMID: 31960604)
Semin Arthritis Rheum. 2021 Oct;51(5):e13. (PMID: 33358002)
Pediatr Rheumatol Online J. 2010 Jul 08;8:20. (PMID: 20615240)
J Rheumatol. 2021 Jul;48(7):967-968. (PMID: 33795329)
RMD Open. 2018 Dec 05;4(2):e000756. (PMID: 30714580)
S Afr J Physiother. 2019 Jul 30;75(1):1335. (PMID: 31392295)
Ann Rheum Dis. 2000 Feb;59(2):81-2. (PMID: 10666159)
J Clin Rheumatol. 2016 Dec;22(8):405-410. (PMID: 27870762)
Clin Rheumatol. 2015 May;34(5):819-29. (PMID: 25501633)
Int J Rheum Dis. 2009 Dec;12(4):279-82. (PMID: 20374362)
Pediatr Rheumatol Online J. 2021 Dec 2;19(1):166. (PMID: 34857004)
Pediatr Rheumatol Online J. 2021 May 07;19(1):69. (PMID: 33962643)
Rheum Dis Clin North Am. 2019 Feb;45(1):13-26. (PMID: 30447742)
Rheumatol Int. 2023 Apr;43(4):705-712. (PMID: 36178500)
Int J Rheum Dis. 2017 May;20(5):647-653. (PMID: 26864133)
Nat Rev Rheumatol. 2014 Mar;10(3):132-4. (PMID: 24514914)
Arthritis Rheum. 2001 Sep;44(9):1971-4. (PMID: 11592356)
Arthritis Care Res (Hoboken). 2022 Mar;74(3):340-348. (PMID: 33107674)
Pediatr Rheumatol Online J. 2011 Aug 16;9:23. (PMID: 21846336)
Pediatr Rheumatol Online J. 2011 Sep 12;9:26. (PMID: 21910871)
Pediatr Rheumatol Online J. 2011 Aug 15;9:24. (PMID: 21843335)
Pediatr Rheumatol Online J. 2012 Oct 10;10(1):35. (PMID: 23050608)
Korean J Intern Med. 2019 May;34(3):660-668. (PMID: 29232941)
Clin Exp Rheumatol. 2009 Sep-Oct;27(5):863-9. (PMID: 19917175)
Pediatr Rheumatol Online J. 2023 Jan 21;21(1):6. (PMID: 36681840)
J Pediatr. 2006 Dec;149(6):869-870. (PMID: 17137909)
J Rheumatol. 2016 Jun;43(6):1121-9. (PMID: 27036382)
Healthc Policy. 2021 Feb;16(3):119-134. (PMID: 33720829)
Ann Rheum Dis. 2005 Jun;64(6):875-80. (PMID: 15897308)
معلومات مُعتمدة: Pfizer Grant ID 75430581 Pfizer Pharmaceuticals
فهرسة مساهمة: Keywords: Africa; Global Health; Juvenile idiopathic arthritis; Paediatric rheumatology
المشرفين على المادة: 0 (Antirheumatic Agents)
تواريخ الأحداث: Date Created: 20240722 Date Completed: 20240723 Latest Revision: 20240725
رمز التحديث: 20240726
مُعرف محوري في PubMed: PMC11264440
DOI: 10.1186/s12969-024-01000-3
PMID: 39039515
قاعدة البيانات: MEDLINE
الوصف
تدمد:1546-0096
DOI:10.1186/s12969-024-01000-3